OTC Markets OTCPK - Delayed Quote USD

CareRx Corporation (CHHHF)

Compare
1.4100
-0.1200
(-7.84%)
At close: January 17 at 9:36:20 AM EST
Currency in CAD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
365,630.0000
370,746.0000
381,727.0000
262,630.0000
162,196.0000
Cost of Revenue
259,234.0000
266,048.0000
271,793.0000
187,351.0000
115,143.0000
Gross Profit
106,396.0000
104,698.0000
109,934.0000
75,279.0000
47,053.0000
Operating Expense
97,292.0000
97,472.0000
102,301.0000
70,468.0000
48,257.0000
Operating Income
9,104.0000
7,226.0000
7,633.0000
4,811.0000
-1,204.0000
Net Non Operating Interest Income Expense
-10,114.0000
-13,013.0000
-14,943.0000
-14,589.0000
-2,952.0000
Other Income Expense
-5,119.0000
-3,808.0000
-28,586.0000
-13,957.0000
-14,145.0000
Pretax Income
-6,129.0000
-9,595.0000
-35,896.0000
-23,735.0000
-18,301.0000
Tax Provision
-173.0000
-4,190.0000
-1,543.0000
-1,005.0000
-118.0000
Net Income Common Stockholders
-5,956.0000
-5,405.0000
-34,353.0000
-22,730.0000
-18,262.0000
Diluted NI Available to Com Stockholders
-5,956.0000
-5,405.0000
-34,353.0000
-22,730.0000
-18,262.0000
Basic EPS
-0.10
-0.09
-0.72
-0.65
-0.90
Diluted EPS
-0.10
-0.09
-0.72
-0.65
-0.90
Basic Average Shares
59,683.5480
57,350.0000
47,596.0000
34,858.0000
20,266.0000
Diluted Average Shares
59,683.5480
57,350.0000
47,596.0000
34,858.0000
20,266.0000
Total Operating Income as Reported
5,164.0000
4,670.0000
-21,944.0000
-3,307.0000
-12,324.0000
Total Expenses
356,526.0000
363,520.0000
374,094.0000
257,819.0000
163,400.0000
Net Income from Continuing & Discontinued Operation
-5,956.0000
-5,405.0000
-34,353.0000
-22,730.0000
-18,262.0000
Normalized Income
-981.4913
-3,120.2000
-6,995.7775
-9,363.9747
-4,129.2032
Interest Income
329.0000
1,257.0000
278.0000
58.0000
58.0000
Interest Expense
10,542.0000
14,270.0000
15,221.0000
14,492.0000
1,425.0000
Net Interest Income
-10,114.0000
-13,013.0000
-14,943.0000
-14,589.0000
-2,952.0000
EBIT
4,413.0000
4,675.0000
-20,675.0000
-9,243.0000
-16,876.0000
EBITDA
23,765.0000
24,651.0000
-610.0000
6,150.0000
-5,418.0000
Reconciled Cost of Revenue
259,234.0000
266,048.0000
271,793.0000
187,351.0000
115,143.0000
Reconciled Depreciation
19,352.0000
19,976.0000
20,065.0000
15,393.0000
11,458.0000
Net Income from Continuing Operation Net Minority Interest
-5,956.0000
-5,405.0000
-34,353.0000
-22,730.0000
-18,183.0000
Total Unusual Items Excluding Goodwill
-5,119.0000
-3,808.0000
-28,586.0000
-13,957.0000
-14,145.0000
Total Unusual Items
-5,119.0000
-3,808.0000
-28,586.0000
-13,957.0000
-14,145.0000
Normalized EBITDA
28,884.0000
28,459.0000
27,976.0000
20,107.0000
8,727.0000
Tax Rate for Calcs
0.0000
0.0004
0.0000
0.0000
0.0000
Tax Effect of Unusual Items
-144.4913
-1,523.2000
-1,228.7775
-590.9747
-91.2032
12/31/2020 - 7/13/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers